Study of Hallucinations in Patients With Borderline Personality Disorder
Launched by UNIVERSITY HOSPITAL, TOULOUSE · Apr 25, 2018
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
The borderline personality disorder (BPD) is a very common personality disorder which concerns about 1.35% of total population. It is characterized by an affective, emotional, social and professional instability and an important association with comorbidities like mood disorders, post-traumatic stress disorder, addictive problems and suicide mortality. Hallucinations seem to be frequent in this personality disorder, but are not often taken in consideration by nursing staff because of massive need of attention of this kind of patient. At this moment there is no study of prevalence of this tr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient aged 18 and under 75
- • Patient with borderline personality disorder (formerly or newly diagnosed diagnosis)
- • Patient having given his opposition to his participation in research
- Exclusion Criteria:
- • Schizophrenia
- • Major depressive episode characterized in progress
- • Manic or hypomanic episode in progress
- • History of head trauma
- • Stroke, Parkinson's disease, dementia
- • Autism
- • Mental retardation
- • Patient under the age of 75
- • Patient who does not read or speak French
- • Patient unable to give consent (includes protected persons: guardianship, trusteeship)
- • Incarcerated patient
About University Hospital, Toulouse
The University Hospital of Toulouse is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific inquiry with comprehensive clinical services. Its multidisciplinary team of healthcare professionals collaborates with renowned researchers to facilitate pioneering studies across various medical fields, aiming to enhance treatment options and improve patient outcomes. As a prominent institution in the region, the University Hospital of Toulouse is committed to fostering an environment of excellence in both education and research within the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Trial Officials
Anjali Mathur, MD
Principal Investigator
University Hospital, Toulouse
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials